Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. Read more about Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults.
HBV-positive and HIV-positive organs in transplantation: A clinical guide for the hepatologist. Read more about HBV-positive and HIV-positive organs in transplantation: A clinical guide for the hepatologist.
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. Read more about BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.
Non-invasive alloimmune risk stratification of long-term liver transplant recipients. Read more about Non-invasive alloimmune risk stratification of long-term liver transplant recipients.
TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis. Read more about TBX3 functions as a tumor suppressor downstream of activated CTNNB1 mutants during hepatocarcinogenesis.
A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival. Read more about A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma. Read more about MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinoma.
Systemic therapies for intrahepatic cholangiocarcinoma. Read more about Systemic therapies for intrahepatic cholangiocarcinoma.
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis. Read more about Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis.
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice. Read more about Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
